Literature DB >> 22198749

Synthesis and application of superparamagnetic iron oxide nanoparticles in targeted therapy and imaging of cancer.

Liangqian Tong1, Ming Zhao, Shu Zhu, Jing Chen.   

Abstract

Superparamagnetic iron oxide (SPIO) nanoparticles have become a popular strategy of cancer treatment and molecular imaging because of their versatile properties and biocompatibility. A variety of studies have shown the exciting potential of functionalized SPIO nanoparticles, such as surface-coated, targeted ligandconjugated, and/or drug-loaded SPIO nanoparticles, as powerful tools for targeted imaging and therapy. Moreover, the applications of SPIO nanoparticles that integrate diagnosis and therapy in SPIO nanoparticles facilitate the monitoring of therapeutic efficacy during treatment. In the present review, we primarily concentrate on the recent advancements in the field of SPIO nanoparticles in terms of synthesis, targeted therapy, and cancer imaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198749     DOI: 10.1007/s11684-011-0162-6

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  53 in total

1.  Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro.

Authors:  Forrest M Kievit; Freddy Y Wang; Chen Fang; Hyejung Mok; Kui Wang; John R Silber; Richard G Ellenbogen; Miqin Zhang
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

2.  Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer.

Authors:  Jin Hee Maeng; Don-Haeng Lee; Kyung Hee Jung; You-Han Bae; In-Suh Park; Seok Jeong; Yong-Sun Jeon; Chang-Koo Shim; Wooyoung Kim; Jungahn Kim; Jeongmi Lee; Yoon-Mi Lee; Ji-Hee Kim; Won-Hong Kim; Soon-Sun Hong
Journal:  Biomaterials       Date:  2010-03-26       Impact factor: 12.479

3.  Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.

Authors:  Akiko Sato; Yasuaki Tamura; Noriyuki Sato; Toshiharu Yamashita; Tomoaki Takada; Makito Sato; Yasue Osai; Masae Okura; Ichiro Ono; Akira Ito; Hiroyuki Honda; Kazumasa Wakamatsu; Shosuke Ito; Kowichi Jimbow
Journal:  Cancer Sci       Date:  2010-09       Impact factor: 6.716

4.  Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling.

Authors:  Michal Babic; Daniel Horák; Miroslava Trchová; Pavla Jendelová; Katerina Glogarová; Petr Lesný; Vít Herynek; Milan Hájek; Eva Syková
Journal:  Bioconjug Chem       Date:  2008-02-21       Impact factor: 4.774

5.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

6.  Tat-BMPs-PAMAM conjugates enhance therapeutic effect of small interference RNA on U251 glioma cells in vitro and in vivo.

Authors:  Lei Han; Anling Zhang; Hanjie Wang; Peiyu Pu; Xinguo Jiang; Chunsheng Kang; Jin Chang
Journal:  Hum Gene Ther       Date:  2010-04       Impact factor: 5.695

Review 7.  Targeting multidrug resistance in cancer.

Authors:  Gergely Szakács; Jill K Paterson; Joseph A Ludwig; Catherine Booth-Genthe; Michael M Gottesman
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

8.  Application of nanotechnology in cancer therapy and imaging.

Authors:  Xu Wang; Lily Yang; Zhuo Georgia Chen; Dong M Shin
Journal:  CA Cancer J Clin       Date:  2008-01-28       Impact factor: 508.702

9.  Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging.

Authors:  Esther Amstad; Stefan Zurcher; Alireza Mashaghi; Joyce Y Wong; Marcus Textor; Erik Reimhult
Journal:  Small       Date:  2009-06       Impact factor: 13.281

10.  Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery.

Authors:  Marina Talelli; Cristianne J F Rijcken; Twan Lammers; Peter R Seevinck; Gert Storm; Cornelus F van Nostrum; Wim E Hennink
Journal:  Langmuir       Date:  2009-02-17       Impact factor: 3.882

View more
  16 in total

1.  Target-specific delivery of oxaliplatin to HER2-positive gastric cancer cells in vivo using oxaliplatin-au-fe3o4-herceptin nanoparticles.

Authors:  Daren Liu; Xiaowen Li; Changlei Chen; Chao Li; Chuanbiao Zhou; Weidong Zhang; Jiangang Zhao; Jie Fan; Kai Cheng; Li Chen
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

Review 2.  Clinically Approved Nanoparticle Imaging Agents.

Authors:  Avnesh S Thakor; Jesse V Jokerst; Pejman Ghanouni; Jos L Campbell; Erik Mittra; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2016-10-13       Impact factor: 10.057

Review 3.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

4.  Toxicological Aspects of Iron Oxide Nanoparticles.

Authors:  Natalia Fernández-Bertólez; Carla Costa; Fátima Brandão; João Paulo Teixeira; Eduardo Pásaro; Vanessa Valdiglesias; Blanca Laffon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Ligand-targeted theranostic nanomedicines against cancer.

Authors:  Virginia J Yao; Sara D'Angelo; Kimberly S Butler; Christophe Theron; Tracey L Smith; Serena Marchiò; Juri G Gelovani; Richard L Sidman; Andrey S Dobroff; C Jeffrey Brinker; Andrew R M Bradbury; Wadih Arap; Renata Pasqualini
Journal:  J Control Release       Date:  2016-01-06       Impact factor: 9.776

6.  Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.

Authors:  Noriko Satake; Connie Duong; Cathy Chen; Gustavo A Barisone; Elva Diaz; Joseph Tuscano; David M Rocke; Jan Nolta; Nitin Nitin
Journal:  Br J Haematol       Date:  2014-09-08       Impact factor: 6.998

Review 7.  Tracking Transplanted Stem Cells Using Magnetic Resonance Imaging and the Nanoparticle Labeling Method in Urology.

Authors:  Jae Heon Kim; Hong J Lee; Yun Seob Song
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

8.  Bcl-2-functionalized ultrasmall superparamagnetic iron oxide nanoparticles coated with amphiphilic polymer enhance the labeling efficiency of islets for detection by magnetic resonance imaging.

Authors:  Bin Yang; Haolei Cai; Wenjie Qin; Bo Zhang; Chuanxin Zhai; Biao Jiang; Yulian Wu
Journal:  Int J Nanomedicine       Date:  2013-10-16

9.  Evaluation of superparamagnetic iron oxide-polymer composite microcapsules for magnetic resonance-guided high-intensity focused ultrasound cancer surgery.

Authors:  Yang Sun; Yuanyi Zheng; Pan Li; Dong Wang; Chengcheng Niu; Yuping Gong; Rongzhong Huang; Zhibiao Wang; Zhigang Wang; Haitao Ran
Journal:  BMC Cancer       Date:  2014-11-03       Impact factor: 4.430

10.  Magnetofection: a reproducible method for gene delivery to melanoma cells.

Authors:  Lara Prosen; Sara Prijic; Branka Music; Jaka Lavrencak; Maja Cemazar; Gregor Sersa
Journal:  Biomed Res Int       Date:  2013-06-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.